Adult Clinical Trials in Wuhan, Hubei
7 recruitingWuhan, Hubei, China
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
GT201 Injection For The Treatment Of Advanced Solid Tumors
Solid Tumor, Adult
Grit Biotechnology18 enrolled4 locationsNCT06144671
Recruiting
Phase 1
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
AdultAdvanced Clear Renal Cell Carcinoma
Grit Biotechnology12 enrolled1 locationNCT06819293
Recruiting
Phase 2
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Adult
Grit Biotechnology83 enrolled24 locationsNCT06241781
Recruiting
Phase 1
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Solid Tumor, AdultGastrointestinal Stromal Tumor (GIST)
Ascentage Pharma Group Inc.100 enrolled6 locationsNCT03594422
Recruiting
Phase 1Phase 2
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Solid Tumor, Adult
DualityBio Inc.360 enrolled36 locationsNCT06554795
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled58 locationsNCT06760273